Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Filed Mar 10, 2017 · 10-K · 69 days after period end · 0001640334-17-000456
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$1.12M | -$691.18K | -$1.70M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 10, 2017 · 69 d after period end
